查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198725

血管移植物市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Vascular Graft Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内（2022 年至 2027 年），血管移植物市场的复合年增长率预计为 5.7%。

由于运营、供应链、分销系统等方面的中断，COVID-19 爆发对血管移植物市场产生了不利影响。 此外，许多择期手术已被取消或推迟，以遏制冠状病毒的传播。 例如，根据 2020 年 5 月在英国外科杂誌上发表的一项研究“因 COVID-19 大流行而取消选择性手术：全球预测模型为手术恢復计划提供信息”，COVID 导致医院服务中断的高峰期-19以12週时间计算，2020年全球约有2840万例择期手术被取消或推迟。 这些研究表明，COVID-19感染在预测期内对血管移植市场产生了重大影响。

推动市场增长的主要因素包括透析程序的增加和全球慢性肾病 (CKD) 患者的增加。 据国家肾臟基金会称，2020 年将有超过 200 万人接受透析治疗。 在美国，肾臟疾病估计影响了 3700 万人（占成年人口的 15%，或超过七分之一的成年人）。 此外，心血管疾病、糖尿病和终末期肾病的流行也有望推动市场。 心血管疾病（CVD）是美国主要的死亡原因之一，根据世界卫生组织2020年发布的数据，2019年估计有1790万人死于CVD。

此外，根据国际肾脏病学会（ISN）和国际肾臟基金会联合会（IFKF）联合举办的“世界肾臟日”公布的数据，2020年，约有8.5亿人受到影响由肾臟疾病。 据估计，每 10 个成年人中就有 1 个患有慢性肾病 (CKD)。 CKD 的全球负担持续增加，预计到 2040 年将成为全球损失生命年的第五大原因。

血管移植物的广泛使用，例如电纺聚氨酯血管移植物用于復杂的血管创伤（因为它们可以降低新内膜形成的风险）预计将在预测期内推动市场。

此外，专注于推出创新产品的市场参与者正在推动市场的增长。 例如，2021 年 9 月，Terumo Aortic 开始探索 PANTHER 针织和机织外科移植物的世界。 主要参与者为扩大和加强市场而采取的併购、合作和伙伴关係等战略也将推动增长。

除上述因素外，遗传和遗传因素、不健康的生活方式、饮酒和吸烟预计都会增加对血管移植物的需求。 在新兴国家，低报销率和不断上升的自付费用可能会限制市场增长。

血管移植物市场趋势

肾功能衰竭部分预计在预测期内增长

由于患有肾病、终末期肾病的患者数量不断增加以及移植物的可用性，预计肾衰竭部分在预测期内增长最快。 肾衰竭的治疗方法是用肾移植代替肾臟。 在此过程中使用血管移植物。 肾移植使用血管移植物来重建肾臟的血管。

例如，在国际肾脏病学会（ISN）和国际肾臟基金会联合会（IFKF）于2020年3月联合举办的“世界肾臟日”上，目前全球约有8.5亿人患有肾臟疾病。据称受苦，预计到 2040 年将成为全球损失岁月的第五大原因。 此外，2020年，肾臟基金会发布的一份报告发现，加拿大约有400万人患有肾臟疾病，其中46%的新病例年龄在65岁以下。 此外，根据同一消息来源，自 2009 年以来，患有终末期肾病的人数增加了 35%。 因此，由于慢性肾脏病患病率上升，预计市场在预测期内将出现高速增长。

此外，2022 年 5 月，加州再生医学研究所 (CIRM) 要求加州大学戴维斯分校的王爱军教授为治疗肾衰竭的血液透析患者开发一种智能、耐用的血管装置。授予 300 万美元的资助，用于 该装置使用一种独特的分子来引导体内的干细胞，以帮助防止合成血管移植物的失败。 同样在 2021 年 7 月，Vascudyne 首次将其 TRUE 血管移植物用于需要血液透析通路的终末期肾病患者。

因此，预计终末期肾病发病率的增加将增加对血管移植物的需求，并有助于市场增长。

预计在预测期内北美将占据最大的市场份额

北美主导着血管移植物市场。 北美由于糖尿病、心血管疾病和慢性肾病的高患病率而保持主导地位。 报销计划的存在和最先进的医疗保健基础设施的可用性正在推动北美这个市场的增长。

根据 2020 年心脏病和中风统计情况说明书，预计美国每年至少有 40,000 名婴儿会受到先天性心脏病的影响。 这些婴儿中约有 25%（每 1,000 名活产婴儿中有 2.4 名）在出生后的第一年内需要接受治疗。 根据美国疾病控制和预防中心 (CDC) 的数据，到 2030 年，美国房颤的患病率估计将增加到 1210 万。 心脏病患病率的上升预计将在未来几年推动血管移植市场的增长。

此外，根据美国国家糖尿病、胃肠病学和肾臟疾病研究所的数据，到 2021 年，慢性肾病将影响美国超过七分之一的成年人，估计有 3700 万美国人。据说 随着慢性肾病患者数量的增加，对血管移植物的需求也在增加。 预计这将在预测期内推动该地区的市场增长。

此外，新产品在市场上的推出和批准将推动市场的持续增长达到新的高度。 例如，2020 年 9 月，Terumo Aortic 在美国推出了 Treo 腹部覆膜支架系统。 此外，2021 年 3 月，Vascular Grafts Solutions (VGS) Ltd. 获得了美国食品和药物管理局 (USFDA) 的上市许可，用于冠状动脉旁路移植术 (CABG) 中的新型无夹钳近端吻合装置 VIOLA。我得到了

因此，由于上述因素，预计北美地区在预测期内将出现显着增长。

血管移植市场竞争对手分析

血管移植市场竞争激烈，由几家大型企业组成。 这些主要参与者中的大多数都在全球开展业务，并在新兴市场面临激烈的竞争。 市场上的主要参与者包括雅培实验室、B. Braun Melsungen AG、Bard Peripheral Vascular Inc (BD)、Cardinal Health (Cordis)、Cook Medical、Cryolife、Getinge Group、LeMaitre Vascular Inc、Medtronic plc、Terumo Medical Corporation、W.L. Includes许多参与者，例如 Gore & Associates Inc.

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 改善生活方式相关疾病的患病率
    • 血管移植支架材料和设计的技术进步
  • 市场製约因素
    • 不利的赎回情景
    • 与移植失败相关的高风险
  • 五力分析分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • 血液透析通路移植物
    • 血管内覆膜支架
    • 外周血管移植
    • 冠状动脉旁路移植术
  • 通过使用
    • 动脉瘤
    • 肾功能衰竭
    • 血管阻塞
    • 冠状动脉疾病
    • 其他用途
  • 按原材料
    • 合成材料
    • 生物原料
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company（Bard Peripheral Vascular Inc.）
    • Cardinal Health（Cordis Corporation）
    • Cook Medical
    • Cryolife
    • Getinge Group
    • LeMaitre Vascular Inc
    • Medtronic PLC
    • Terumo Medical Corporation
    • W.L. Gore & Associates Inc
    • Endologix Inc.
    • Vascular Graft Solution Ltd.
    • OrbusNeich

第7章 市场机会与今后动向

简介目录
Product Code: 62301

The vascular graft market is projected to register a CAGR of 5.7% during the forecast period (2022 - 2027).

The outbreak of COVID-19 had a negative impact on the vascular grafts market due to the disruption in operations, supply chains, distribution systems, etc. Also, many elective procedures were canceled or postponed to control the spread of coronavirus. For instance, according to the study published in the British Journal of Surgery in May 2020, "Elective surgery cancellations due to the COVID-19 pandemic: global predictive modeling to inform surgical recovery plans" based on 12 weeks of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed in 2020. Such studies show that the COVID-19 infection has significantly impacted the vascular graft market over the forecast period.

Key factors driving the market growth include the increasing number of dialysis procedures and rising chronic kidney disease (CKD) cases globally. According to the National Kidney Foundation, in 2020, over 2 million people received treatment for dialysis. Kidney disease affects an estimated 37 million people in the United States (15% of the adult population; more than 1 in 7 adults). Moreover, the prevalence of cardiovascular diseases, diabetes, and end-stage renal disease is also expected to drive the market. Cardiovascular disease (CVD) is one of the leading causes of death in the United States, and according to the data published by World Health Organization in 2020, an estimated 17.9 million people died due to CVD in 2019.

Moreover, in 2020, as per data released on World Kidney Day, a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF), kidney disease affected around 850 million people globally. As per estimates, one in ten adults has chronic kidney disease (CKD). The global burden of CKD is continuously increasing and is projected to become the 5th most common cause of years of life lost globally by 2040.

The extensive use of prosthetic grafts such as electrospun polyurethane vascular grafts for complex vascular trauma (as it reduces the risk of neointimal formation) is expected to propel the market over the forecast period.

Furthermore, the market players focusing on introducing innovative products are fueling the market growth. For instance, in September 2021, Terumo Aortic launched PANTHER - a global surgical graft study of knitted and woven surgical grafts. Also, strategies such as mergers & acquisitions, collaborations, and partnerships adopted by key players to expand and strengthen the market propel the growth.

Besides the mentioned factors, genetic and hereditary factors, unhealthy lifestyle, alcohol consumption, and tobacco smoking, among others, are expected to increase the demand for vascular grafts. A low reimbursement rate and rising out-of-pocket expenses in emerging economies can restrain the market growth.

Vascular Graft Market Trends

Kidney Failure Segment is Expected to Witness Growth Over the Forecast Period

The kidney failure segment is expected to witness the fastest growth during the forecast period owing to the increasing number of patients with kidney diseases, end-stage kidney failure, and the availability of procedures using grafts. Kidney Failure is treated by replacing a kidney through a kidney transplant. This process uses vascular grafts. The renal vessel is reconstructed in kidney transplantation using vascular grafts.

For instance, on World Kidney Day, a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF) in March 2020, it was stated that currently, around 850 million people globally suffer from a kidney disorder, and it is expected to become the 5th most common cause of years of life lost globally by 2040. Additionally, in 2020, a report published by Kidney Foundation stated that around 4 million people have kidney disease in Canada, of which 46% of new patients are under 65. Moreover, as per the same source, the number of people living with end-stage kidney disease has grown by 35% since 2009. Hence, owing to the rising prevalence of chronic kidney diseases, the market is expected to witness high growth over the forecast period.

Furthermore, in May 2022, the California Institute for Regenerative Medicine (CIRM) awarded UC Davis Professor Aijun Wang a USD 3 million grant to develop a smart, durable vascular device for hemodialysis patients treated for kidney failure. This device uses a unique molecule that guides the body's stem cells to help prevent the failure of synthetic vascular grafts. Also, in July 2021, Vascudyne used its TRUE Vascular Graft in end-stage renal disease patients requiring hemodialysis access first time on a human.

Hence, the increasing incidence of end-stage kidney failure is expected to increase the demand for vascular grafts, which will also help the market's growth.

North America is Expected to Retain Largest Market Share Over the Forecast Period

North America dominates the vascular graft market. North America maintained its dominant share due to the high prevalence rate of diabetes, cardiovascular diseases, and chronic kidney disease. The presence of reimbursement coverage and availability of state-of-the-art healthcare infrastructure are driving the growth of this market in North America.

Heart Disease & Stroke Statistical Fact Sheet 2020 estimates that a minimum of 40,000 infants are expected to be affected yearly by congenital heart defects in the United States. About 25% or 2.4 (per 1,000 live births) of these infants require treatment in the first year of life. In addition, according to the Centers for Disease Control and Prevention (CDC), in the United States, the prevalence of atrial fibrillation is estimated to rise to 12.1 million by the year 2030. The rise in the prevalence of cardiac diseases is expected to boost the vascular graft market growth in the coming years.

Moreover, as per the National Institute of Diabetes and Digestive and Kidney Diseases, in 2021, Chronic Kidney Disease affected more than 1 in 7 US adults, an estimated 37 million Americans. With the increase in chronic kidney disease cases, there is a need for vascular grafts. This is expected to enhance the market growth in the region during the forecast period.

Also, new product launches and approval in the market will push the market to continue to grow to new heights. For instance, in September 2020, Terumo Aortic Launched Treo Abdominal Stent Graft System in the United States. Moreover, in March 2021, Vascular Grafts Solutions (VGS) Ltd. received marketing clearance from the United States Food and Drug Administration (USFDA) for the VIOLA, a new device for clampless proximal anastomosis in coronary artery bypass grafting (CABG).

Thus, owing to the abovementioned factors, the North American region is expected to show significant growth over the forecast period.

Vascular Graft Market Competitor Analysis

The vascular graft market is fairly competitive and consists of several major players. Most of these major players enjoy a global presence, and they are facing intense competition in emerging economies. Key players in the market include Abbott Laboratories, B. Braun Melsungen AG, Bard Peripheral Vascular Inc. (BD), Cardinal Health (Cordis), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic plc, Terumo Medical Corporation, and W.L. Gore & Associates Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Lifestyle-related Disorders
    • 4.2.2 Technological Advancements in the Scaffold Material and Design of Vascular Grafts
  • 4.3 Market Restraints
    • 4.3.1 Unfavorable Reimbursement Scenario
    • 4.3.2 High Risk Associated with Graft Failures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Hemodialysis Access Graft
    • 5.1.2 Endovascular Stent Graft
    • 5.1.3 Peripheral Vascular Graft
    • 5.1.4 Coronary Artery By-pass Graft
  • 5.2 By Application
    • 5.2.1 Aneurysms
    • 5.2.2 Kidney Failure
    • 5.2.3 Vascular Occlusion
    • 5.2.4 Coronary Artery Diseases
    • 5.2.5 Other Applications
  • 5.3 By Raw Material
    • 5.3.1 Synthetic Raw Material
    • 5.3.2 Biological Raw Material
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
    • 6.1.4 Cardinal Health (Cordis Corporation)
    • 6.1.5 Cook Medical
    • 6.1.6 Cryolife
    • 6.1.7 Getinge Group
    • 6.1.8 LeMaitre Vascular Inc
    • 6.1.9 Medtronic PLC
    • 6.1.10 Terumo Medical Corporation
    • 6.1.11 W.L. Gore & Associates Inc
    • 6.1.12 Endologix Inc.
    • 6.1.13 Vascular Graft Solution Ltd.
    • 6.1.14 OrbusNeich

7 MARKET OPPORTUNITIES AND FUTURE TRENDS